Truist Securities Reiterates Buy Rating on Regeneron Pharma (REGN) following Ph3 study results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/21/2026

1. BA
2. SPY
3. USO
4. RTX
5. AMC
6. NVDA
7. XFLT
8. GE
9. DPZ
10. EVEX

Go back to Truist Securities Reiterates Buy Rating on Regeneron Pharma (REGN) following Ph3 study results
Regeneron (NASDAQ: REGN) Delayed: 672.15 -4.54 (0.67%)
Previous Close $676.69    52 Week High $592.36 
Open $674.72    52 Week Low $325.35 
Day High $681.74    P/E 176.42 
Day Low $669.88    EPS $3.81 
Volume 624,791